Vera Therapeutics (VERA) Stock Highlights

42.6 | +1.31%

2024-12-21 03:02:02

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The companys lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Statistics

Range Today

40.96 45.06

Volume Today 2.23M

Range 1 Year

14.2 51.61

Volume 1 Year 216.1M

Range 3 Year

5.2 51.61

Volume 3 Year 400.3M

Range 10 Year

5.2 51.61

Volume 10 Year 409.59M

Highlights

Market Capitalization 3.05B (mid)

Floating Shares 40.22M

Current Price 42.6

Price To Earnings -22.46

Price To Book 21.02

Earnings Per Share -2.15

Payout Ratio 0%

Performance

Latest +1.31%

1 Month -7.61%

3 Months +1.31%

6 Months +20.14%

1 Year +167.92%

3 Years +84.42%

5 Years +258.28%

10 Years +258.28%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.